National Vision Holdings, Inc.

EYE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $1.99B $1.82B $1.76B $1.64B $1.71B $1.72B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $1.02B $938.5M $904.8M $832.6M $725.0M $744.5M
Operating Income $58.8M $-10.4M $24.5M $52.8M $87.0M $73.6M
Operating Margin 3.0% -0.6% 1.4% 3.2% 5.1% 4.3%
Interest Expense $25.6M $48.3M $33.3M
Pretax Income $41.7M $-25.7M $9.6M $52.3M $38.7M $30.5M
Income Tax Expense $12.1M $1.5M $6.0M $15.5M $2.4M $-2.3M
Net Income $29.6M $-28.5M $-65.9M $42.1M $36.3M $32.8M
Net Margin 1.5% -1.6% -3.8% 2.6% 2.1% 1.9%
EPS (Basic) $0.37 $-0.36 $-0.84 $0.53 $0.45 $0.42
EPS (Diluted) $0.37 $-0.36 $-0.84 $0.52 $0.44 $0.40
Shares Outstanding (Basic) 79.1M 78.8M 78.6M 78.3M 79.8M 80.6M 80.2M 78.6M
Shares Outstanding (Diluted) 80.6M 78.8M 78.6M 78.6M 80.3M 82.8M 80.2M 81.7M
Dividends Per Share
← Newer Page 1 of 2 Older →